Literature DB >> 17044868

Immunoglobulin enhancer HS1,2 polymorphism: a new powerful anthropogenetic marker.

V Giambra1, C Martínez-Labarga, M Giufré, D Modiano, J Simporé, B K Gisladottir, R Francavilla, G Zhelezova, S S Kilic, M Crawford, G Biondi, O Rickards, D Frezza.   

Abstract

The human HS1,2 enhancer of the immunoglobulin (Ig) heavy chain 3' enhancer complex plays a central role in the regulation of Ig maturation and production. Four common alleles HS1,2-A*1, *2, *3, *4 are directly implicated with the transcription level and at least one of them, HS1, 2-A*2, seems to be related to immune disorders, such as coeliac disease, herpetiform dermatitis and Berger syndrome. Given their clinical significance it is of interest to know the distribution of HS1,2-A variants in populations from different continents, as well as to determine whether the polymorphism is associated to specific evolutionary factors. In this paper we report the distribution of the HS1,2-A polymorphism in 1098 individuals from various African, Asian and European populations. HS1,2-A*3 and HS1,2-A*4 alleles are at their highest frequencies among Africans, and HS1,2-A*2 is significantly lower in Africans in comparison with both Europeans and, to a lesser extent, Asians. Analysis of molecular variance of the allele frequencies indicates that the HS1,2-A polymorphism can be considered as a reliable anthropogenetic marker.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17044868     DOI: 10.1111/j.1469-1809.2006.00273.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  7 in total

1.  Allelic frequencies of the hs1.2 enhancer within the immunoglobulin heavy chain region in Dayton, Ohio patients screened for celiac disease with duodenal biopsy.

Authors:  Jing Liu; Rebecca A Law; Paul G Koles; Jonathan C Saxe; Michael Bottomley; Courtney E W Sulentic
Journal:  Dig Liver Dis       Date:  2017-04-09       Impact factor: 4.088

2.  2,3,7,8-tetrachlorodibenzo-p-dioxin induces transcriptional activity of the human polymorphic hs1,2 enhancer of the 3'Igh regulatory region.

Authors:  Tharu M Fernando; Sharon D Ochs; Jing Liu; Ruth C Chambers-Turner; Courtney E W Sulentic
Journal:  J Immunol       Date:  2012-02-22       Impact factor: 5.422

3.  Allelic frequencies of 3' Ig heavy chain locus enhancer HS1,2-A associated with Ig levels in patients with schizophrenia.

Authors:  D Frezza; V Giambra; C Mattioli; K Piccoli; R Massoud; A Siracusano; M Di Giannantonio; B K Birshtein; I A Rubino
Journal:  Int J Immunopathol Pharmacol       Date:  2009 Jan-Mar       Impact factor: 3.219

4.  Complex sex-biased antibody responses: estrogen receptors bind estrogen response elements centered within immunoglobulin heavy chain gene enhancers.

Authors:  Bart G Jones; Robert E Sealy; Rhiannon R Penkert; Sherri L Surman; Robert W Maul; Geoff Neale; Beisi Xu; Patricia J Gearhart; Julia L Hurwitz
Journal:  Int Immunol       Date:  2019-03-05       Impact factor: 5.071

Review 5.  Epigenetic Regulation of Individual Modules of the immunoglobulin heavy chain locus 3' Regulatory Region.

Authors:  Barbara K Birshtein
Journal:  Front Immunol       Date:  2014-04-21       Impact factor: 7.561

6.  The change in Ig regulation from children to adults disconnects the correlation with the 3'RR hs1.2 polymorphism.

Authors:  Eliseo Serone; Cristina Daleno; Nicola Principi; Laura Porretti; Valentina Iacoacci; Cesare Gargioli; Andrea Magrini; Renato Massoud; Pietro D'Addabbo; Marco Cattalini; Vincenzo Giambra; Alessandro Plebani; Susanna Esposito; Domenico Frezza
Journal:  BMC Immunol       Date:  2014-11-13       Impact factor: 3.615

7.  HS1,2 Ig enhancer alleles association to AIDS progression in a pediatric cohort infected with a monophyletic HIV-strain.

Authors:  Carla Montesano; Vincenzo Giambra; Domenico Frezza; Paolo Palma; Eliseo Serone; Guido Castelli Gattinara; Maurizio Mattei; Giorgio Mancino; Vittorio Colizzi; Massimo Amicosante
Journal:  Biomed Res Int       Date:  2014-05-20       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.